RE: BSspiral: ONC has 19 months of cash on handASS_of_03
The costs of developing a commercial process for large scale production of reovirus isn't synonymous with producing trial scale volumes of reovirus in the lab.
so by insult and implication you are saying that costs of developing large scale production process for reovirus are more than the clinical trials to get it approved.
what is your source, oh wise and learned one? Brad Thompson or someone else?